Orveda's Omnipotent Concentrate is touted as the French bio-tech brand's most potent treatment to date and it works on three axes: the past, present and future. This science-backed serum addresses visible signs of aging by targeting past damage, treating present concerns and supporting resilience going forward.
This soothing and regenerating serum contains 16 actives concentrated at 24% and prebiotics to support healthy, well-balanced skin.
Sue Y. Nabi, CEO of Coty and cofounder of Orveda calls its latest innovation "perhaps the most potent serum of all time." This concentrated serum for all skin types sits at the intersection of scientific innovation in the areas of microbiome and cellular longevity, and it's backed by clinical results to prove its leading edge.
Science-Backed Prebiotic Serums
The Omnipotent Concentrate Targets Past, Present & Future Concerns
Trend Themes
1. Prebiotic Skincare Serums - New science-backed serums harness the power of prebiotics to address past damage, treat present concerns, and support future resilience.
2. Microbiome-focused Innovations - Cutting-edge skincare products are tapping into the potential of the microbiome to deliver targeted results for healthy and well-balanced skin.
3. Cellular Longevity Treatments - Innovative serums are leveraging cellular longevity research to combat visible signs of aging and promote skin regeneration.
Industry Implications
1. Skincare - The skincare industry is embracing the potential of prebiotics, microbiome-focused products, and cellular longevity research to create effective and forward-thinking treatments.
2. Biotechnology - Biotech companies are at the forefront of developing science-backed skincare solutions that incorporate prebiotics and leverage the latest advancements in microbiome and cellular longevity research.
3. Cosmetics - Cosmetics brands are incorporating cutting-edge ingredients and technologies like prebiotics, microbiome research, and cellular longevity to offer consumers innovative serums that target multiple skincare concerns.